消化器健康のグローバル市場(2021〜2031):プレバイオティクス、プロバイオティクス、消化酵素

■ 英語タイトル:Digestive Health Market By Type (Prebiotics, Probiotics, Digestive Enzymes), By Form (Capsule, Tablet, Others), By Distribution Channel (Drug Stores and Retail Pharmacies, Online Providers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:ALD23FB207)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:ALD23FB207
■ 発行日:2022年10月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:310
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Online Only(1名閲覧、印刷不可)USD3,570 ⇒換算¥542,640見積依頼/購入/質問フォーム
Single User(1名閲覧)USD5,730 ⇒換算¥870,960見積依頼/購入/質問フォーム
Enterprise User(閲覧人数無制限)USD9,600 ⇒換算¥1,459,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[消化器健康のグローバル市場(2021〜2031):プレバイオティクス、プロバイオティクス、消化酵素]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Allied Market Research社の本市場調査レポートでは、2021年に38,789.13百万ドルであった世界の消化器健康市場規模が、2031年までに90,205.67百万ドルに到達し、2022年から2031年にかけてCAGR(年平均成長率)8.8%で成長すると予測しています。本レポートは、消化器健康の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、種類別(プレバイオティクス、プロバイオティクス、消化酵素)分析、形態別(カプセル、錠剤、その他)分析、流通チャネル別(ドラッグストア・薬局、オンライン供給者、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、企業状況、企業情報などを掲載しています。また、本レポートは、Bayer AG、GalaxoSmithKline PLC、Pfizer Inc.、Sanofi、Nestle SA、Herbalife Nutrition Ltd.、BASF SE、NOW Health Group Inc.、Amway Corporationなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の消化器健康市場規模:種類別
- プレバイオティクスにおける市場規模
- プロバイオティクスにおける市場規模
- 消化酵素における市場規模
・世界の消化器健康市場規模:形態別
- カプセルにおける市場規模
- 錠剤における市場規模
- その他における市場規模
・世界の消化器健康市場規模:流通チャネル別
- ドラッグストア・薬局チャネルの市場規模
- オンライン供給者チャネルの市場規模
- その他の市場規模
・世界の消化器健康市場規模:地域別
- 北米の消化器健康市場規模
- ヨーロッパの消化器健康市場規模
- アジア太平洋の消化器健康市場規模
- 中南米・中東・アフリカの消化器健康市場規模
・企業状況
・企業情報

世界の消化器健康市場は、2021年には387億8,913万ドルと評価され、2031年には902億5,067万ドルに達し、2022年から2031年までの年平均成長率は8.8%を記録すると予測されています。

消化器系の健康は、誰もが毎日口にする主な関心事の1つです。人の全体的な健康は、不健康な腸によって大きく影響を受ける可能性があるため、同じことを避けるために、体は正常な消化機能を確保し、プロバイオティクスから消化酵素まで幅広い製品を含む食事からの利点を最大化するための栄養素を必要とします。これらは健康的な身体機能を促進し、口から胃までの病原微生物の管理を助けます。さらに、プロバイオティクスのサプリメントは、適切な量を使用することで、消化プロセスを助け、栄養吸収を高めます。

米国立生物工学情報センター(NCBI)によると、消化器系の病気は、アメリカで年間6000万~7000万人が罹患していると推定されており、中でも大腸がんは、アメリカ人男女の間で診断されるがんの種類の第2位となっています。このように、世界中で消化器系疾患の有病率が高まっており、消化器健康製品の必要性がさらに高まっています。
さらに、消化器健康市場の成長は、製薬会社や栄養補助食品会社による製品の数多くの進歩の導入、慢性消化器系疾患の治療ソリューションに対する需要の増加、簡単に入手でき費用対効果の高い幅広い製品やサプリメントの入手可能性によって促進されると予想されます。

さらに、「腸の健康が体重管理のカギを握る」というトレンドの高まりを受けて、プレバイオティクス・メーカーは世界的なプレバイオティクス需要の高まりに対応しようと躍起になっています。研究者たちは、腸内で栄養素の消化・吸収を助ける腸内細菌が減量能力に影響することを発見しました。
スポーツやフィットネス活動の不足に起因する個人の消化器系問題の増加、健康的な栄養摂取への国民の関心の高まり、消化器系の健康のためのプロバイオティクスへの消費者による投資の増加、機能性食品への嗜好の高まり、新製品の発売などが市場の成長を促進します。一方、主要市場企業による研究開発イニシアチブの増加は、市場成長に有利な機会を提供します。

市場成長を促進する様々な要因がありますが、厳しい政府規制や製造プロセスに関連する高い開発コストなど、市場に影響を与えるいくつかの阻害要因もあります。例えば、2002年の公衆衛生安全保障およびバイオテロリズム準備・対応法(バイオテロ法)では、栄養補助食品企業はFDAに登録し、緊急時に企業に連絡するための十分な情報をFDAに提供することが義務付けられています。

消化器健康市場は、製品、形態、流通チャネル、地域によって区分されます。製品別では、プレバイオティクス、プロバイオティクス、消化酵素に分類されます。形態別では、カプセル、錠剤、その他に区分されます。流通チャネル別では、ドラッグストア&小売薬局、オンラインプロバイダー、その他(スーパーマーケット/ハイパーマーケット)に分けられます。 ドラッグストア・小売薬局のセグメントは、さらに処方薬とOTC(一般用医薬品)に細分化されます。地域別では、北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。

本レポートに掲載されている主要企業には、Amway Corporation、Bayer AG、BASF SE、GlaxoSmithKline PLC、Herbalife Nutrition Ltd.、Nestle SA、NOW Health Group Inc.、Pfizer Inc.、Sanofi、Bountiful Company (Nature’s Bounty)などがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの消化器健康市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、消化器健康市場の優勢な機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
・消化器健康市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の消化器健康市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
種類別
プレバイオティクス
プロバイオティクス
消化酵素

形態別
カプセル
錠剤
その他

流通チャネル別
ドラッグストア・薬局
オンラインプロバイダー
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Bayer AG
GalaxoSmithKline PLC
Pfizer Inc.
Sanofi
Nestle SA
Herbalife Nutrition Ltd.
BASF SE
NOW Health Group Inc.
Amway Corporation
The Bountiful Company (Nature’s Bounty)

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Patent Landscape
CHAPTER 4: DIGESTIVE HEALTH MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Prebiotics
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Probiotics
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Digestive Enzymes
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: DIGESTIVE HEALTH MARKET, BY FORM
5.1 Overview
5.1.1 Market size and forecast
5.2 Capsule
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Tablet
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Drug Stores and Retail Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.2.4 Drug Stores and Retail Pharmacies Digestive Health Market by Type
6.2.4.1 Prescription Market size and forecast, by region
6.2.4.2 OTC Market size and forecast, by region
6.3 Online Providers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: DIGESTIVE HEALTH MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Form
7.2.4 North America Market size and forecast, by Distribution Channel
7.2.4.1 North America Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Form
7.2.5.1.3 Market size and forecast, by Distribution Channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Form
7.2.5.2.3 Market size and forecast, by Distribution Channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Form
7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Form
7.3.4 Europe Market size and forecast, by Distribution Channel
7.3.4.1 Europe Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Form
7.3.5.1.3 Market size and forecast, by Distribution Channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Form
7.3.5.2.3 Market size and forecast, by Distribution Channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Form
7.3.5.3.3 Market size and forecast, by Distribution Channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Form
7.3.5.4.3 Market size and forecast, by Distribution Channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Form
7.3.5.5.3 Market size and forecast, by Distribution Channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Form
7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Form
7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
7.4.4.1 Asia-Pacific Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Form
7.4.5.1.3 Market size and forecast, by Distribution Channel
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Form
7.4.5.2.3 Market size and forecast, by Distribution Channel
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Form
7.4.5.3.3 Market size and forecast, by Distribution Channel
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Form
7.4.5.4.3 Market size and forecast, by Distribution Channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Form
7.4.5.5.3 Market size and forecast, by Distribution Channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Form
7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Form
7.5.4 LAMEA Market size and forecast, by Distribution Channel
7.5.4.1 LAMEA Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Form
7.5.5.1.3 Market size and forecast, by Distribution Channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Form
7.5.5.2.3 Market size and forecast, by Distribution Channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Form
7.5.5.3.3 Market size and forecast, by Distribution Channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Form
7.5.5.4.3 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Bayer AG
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 GalaxoSmithKline PLC
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Pfizer Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Sanofi
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Nestle SA
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Herbalife Nutrition Ltd.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 BASF SE
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 NOW Health Group Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Amway Corporation
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 The Bountiful Company (Nature’s Bounty)
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 2. DIGESTIVE HEALTH MARKET, FOR PREBIOTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. DIGESTIVE HEALTH MARKET FOR PREBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. DIGESTIVE HEALTH MARKET, FOR PROBIOTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. DIGESTIVE HEALTH MARKET FOR PROBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. DIGESTIVE HEALTH MARKET, FOR DIGESTIVE ENZYMES, BY REGION, 2021-2031 ($MILLION)
TABLE 7. DIGESTIVE HEALTH MARKET FOR DIGESTIVE ENZYMES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. GLOBAL DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 9. DIGESTIVE HEALTH MARKET, FOR CAPSULE, BY REGION, 2021-2031 ($MILLION)
TABLE 10. DIGESTIVE HEALTH MARKET FOR CAPSULE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. DIGESTIVE HEALTH MARKET, FOR TABLET, BY REGION, 2021-2031 ($MILLION)
TABLE 12. DIGESTIVE HEALTH MARKET FOR TABLET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. DIGESTIVE HEALTH MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. DIGESTIVE HEALTH MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. GLOBAL DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 16. DIGESTIVE HEALTH MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 17. DIGESTIVE HEALTH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 19. DIGESTIVE HEALTH MARKET, FOR PRESCRIPTION, BY REGION, 2021-2031 ($MILLION)
TABLE 20. DIGESTIVE HEALTH MARKET, FOR OTC, BY REGION, 2021-2031 ($MILLION)
TABLE 21. DIGESTIVE HEALTH MARKET, FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 22. DIGESTIVE HEALTH MARKET FOR ONLINE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. DIGESTIVE HEALTH MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. DIGESTIVE HEALTH MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. DIGESTIVE HEALTH MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. U.S. DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. U.S. DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 33. U.S. DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 34. CANADA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. CANADA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 36. CANADA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 37. MEXICO DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 38. MEXICO DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 39. MEXICO DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 40. EUROPE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 41. EUROPE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 42. EUROPE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 43. EUROPE DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 44. EUROPE DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. GERMANY DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 46. GERMANY DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 47. GERMANY DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 48. FRANCE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. FRANCE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 50. FRANCE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 51. UK DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 52. UK DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 53. UK DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 54. ITALY DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 55. ITALY DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 56. ITALY DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 57. SPAIN DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. SPAIN DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 59. SPAIN DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. JAPAN DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 69. JAPAN DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 70. JAPAN DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. CHINA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 72. CHINA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 73. CHINA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 74. AUSTRALIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 75. AUSTRALIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 77. INDIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 78. INDIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 79. INDIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 80. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 81. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 86. LAMEA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 87. LAMEA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 88. LAMEA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 89. LAMEA DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 90. LAMEA DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 91. BRAZIL DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. BRAZIL DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 93. BRAZIL DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 94. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 95. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 96. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 97. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 99. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 103.BAYER AG: COMPANY SNAPSHOT
TABLE 104.BAYER AG: OPERATING SEGMENTS
TABLE 105.BAYER AG: PRODUCT PORTFOLIO
TABLE 106.BAYER AG: NET SALES,
TABLE 107.BAYER AG: KEY STRATERGIES
TABLE 108.GALAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 109.GALAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 110.GALAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 111.GALAXOSMITHKLINE PLC: NET SALES,
TABLE 112.GALAXOSMITHKLINE PLC: KEY STRATERGIES
TABLE 113.PFIZER INC.: COMPANY SNAPSHOT
TABLE 114.PFIZER INC.: OPERATING SEGMENTS
TABLE 115.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 116.PFIZER INC.: NET SALES,
TABLE 117.PFIZER INC.: KEY STRATERGIES
TABLE 118.SANOFI: COMPANY SNAPSHOT
TABLE 119.SANOFI: OPERATING SEGMENTS
TABLE 120.SANOFI: PRODUCT PORTFOLIO
TABLE 121.SANOFI: NET SALES,
TABLE 122.SANOFI: KEY STRATERGIES
TABLE 123.NESTLE SA: COMPANY SNAPSHOT
TABLE 124.NESTLE SA: OPERATING SEGMENTS
TABLE 125.NESTLE SA: PRODUCT PORTFOLIO
TABLE 126.NESTLE SA: NET SALES,
TABLE 127.NESTLE SA: KEY STRATERGIES
TABLE 128.HERBALIFE NUTRITION LTD.: COMPANY SNAPSHOT
TABLE 129.HERBALIFE NUTRITION LTD.: OPERATING SEGMENTS
TABLE 130.HERBALIFE NUTRITION LTD.: PRODUCT PORTFOLIO
TABLE 131.HERBALIFE NUTRITION LTD.: NET SALES,
TABLE 132.HERBALIFE NUTRITION LTD.: KEY STRATERGIES
TABLE 133.BASF SE: COMPANY SNAPSHOT
TABLE 134.BASF SE: OPERATING SEGMENTS
TABLE 135.BASF SE: PRODUCT PORTFOLIO
TABLE 136.BASF SE: NET SALES,
TABLE 137.BASF SE: KEY STRATERGIES
TABLE 138.NOW HEALTH GROUP INC.: COMPANY SNAPSHOT
TABLE 139.NOW HEALTH GROUP INC.: OPERATING SEGMENTS
TABLE 140.NOW HEALTH GROUP INC.: PRODUCT PORTFOLIO
TABLE 141.NOW HEALTH GROUP INC.: NET SALES,
TABLE 142.NOW HEALTH GROUP INC.: KEY STRATERGIES
TABLE 143.AMWAY CORPORATION: COMPANY SNAPSHOT
TABLE 144.AMWAY CORPORATION: OPERATING SEGMENTS
TABLE 145.AMWAY CORPORATION: PRODUCT PORTFOLIO
TABLE 146.AMWAY CORPORATION: NET SALES,
TABLE 147.AMWAY CORPORATION: KEY STRATERGIES
TABLE 148.THE BOUNTIFUL COMPANY (NATURE’S BOUNTY): COMPANY SNAPSHOT
TABLE 149.THE BOUNTIFUL COMPANY (NATURE’S BOUNTY): OPERATING SEGMENTS
TABLE 150.THE BOUNTIFUL COMPANY (NATURE’S BOUNTY): PRODUCT PORTFOLIO
TABLE 151.THE BOUNTIFUL COMPANY (NATURE’S BOUNTY): NET SALES,
TABLE 152.THE BOUNTIFUL COMPANY (NATURE’S BOUNTY): KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD23FB207 )"消化器健康のグローバル市場(2021〜2031):プレバイオティクス、プロバイオティクス、消化酵素" (英文:Digestive Health Market By Type (Prebiotics, Probiotics, Digestive Enzymes), By Form (Capsule, Tablet, Others), By Distribution Channel (Drug Stores and Retail Pharmacies, Online Providers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。